Bruker (BRKRP) Restructuring Costs (2010 - 2025)

Bruker (BRKRP) reported Restructuring Costs of -$3.6 million for Q4 2025, down 110.47% on a YoY basis from $34.4 million in Q4 2024, and down 187.8% quarter-over-quarter from $4.1 million in Q3 2025.

Bruker (BRKRP) Restructuring Costs (2010 - 2025) Analysis & Trends

Bruker has reported Restructuring Costs for 13 years, with the latest figure at -$3.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Restructuring Costs fell 110.47% year-over-year to -$3.6 million; the trailing twelve-month figure through Dec 2025 stood at $41.0 million (up 2.24% YoY), and the FY2025 full-year result was $6.4 million, down 85.75% from the prior year.
  • Restructuring Costs for Q4 2025 stood at -$3.6 million, down from $4.1 million in the prior quarter.
  • The five-year high for Restructuring Costs was $34.4 million in Q4 2024, with the low at -$3.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Bruker - - 379.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.60 Mn
Sep 30, 2025 4.10 Mn
Dec 31, 2024 34.40 Mn
Sep 30, 2024 6.10 Mn
Sep 30, 2020 900,000.00
Dec 31, 2019 -1.30 Mn
Sep 30, 2019 900,000.00
Jun 30, 2019 1.20 Mn
Mar 31, 2019 3.80 Mn
Dec 31, 2018 1.10 Mn
Sep 30, 2018 1.20 Mn
Jun 30, 2018 100,000.00
Mar 31, 2018 1.00 Mn
Dec 31, 2017 700,000.00
Sep 30, 2017 500,000.00
Jun 30, 2017 2.90 Mn
Mar 31, 2017 400,000.00
Dec 31, 2016 900,000.00
Sep 30, 2016 200,000.00
Jun 30, 2016 7.90 Mn